AMPHOTERICIN-B THERAPY - PAST, PRESENT, AND FUTURE

被引：18
作者：
PEACOCK, JE
HERRINGTON, DA
CRUZ, JM
机构：
[1] WAKE FOREST UNIV, BOWMAN GRAY SCH MED, DEPT INTERNAL MED, INFECT DIS SECT, WINSTON SALEM, NC 27103 USA
[2] WAKE FOREST UNIV, BOWMAN GRAY SCH MED, HEMATOL ONCOL SECT, WINSTON SALEM, NC 27103 USA
[3] WAKE FOREST UNIV, CTR COMPREHENS CANC, WINSTON SALEM, NC 27109 USA
来源：
INFECTIOUS DISEASES IN CLINICAL PRACTICE | 1993年 / 2卷 / 02期
关键词：
D O I：
10.1097/00019048-199303000-00001
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：81 / 93
页数：13
相关论文
共 78 条
[41]  
Lopez-Berestein G., 1989, Diagnosis and therapy of systemic fungal infections., P159
[42]  
Macher A M, 1988, Infect Dis Clin North Am, V2, P827
[43]   A REVIEW OF COMPLICATIONS OF AMPHOTERICIN-B THERAPY - RECOMMENDATIONS FOR PREVENTION AND MANAGEMENT [J].
MADDUX, MS ;
BARRIERE, SL .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1980, 14 (03) :177-181
[44]  
MEUNIER F, 1989, AM J MED, V86, P668
[45]  
Meunier F., 1989, REV INFECT DIS S7, V11, pS1605
[46]  
MEUNIERCARPENTI, 1982, COMBINATION ANTIBIOT, P207
[47]   CURRENT ROLE OF THERAPY WITH AMPHOTERICIN-B [J].
MEYER, RD .
CLINICAL INFECTIOUS DISEASES, 1992, 14 :S154-S160
[48]  
MEYERS JD, 1990, SEMIN ONCOL, V17, P10
[49]  
MUHIRCH KH, 1991, 31ST INT C ANT AG CH
[50]   RANDOMIZED, DOUBLE-BLIND TRIAL OF 1-HOUR VERSUS 4-HOUR AMPHOTERICIN-B INFUSION DURATIONS [J].
OLDFIELD, EC ;
GARST, PD ;
HOSTETTLER, C ;
WHITE, M ;
SAMUELSON, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (07) :1402-1406
12345678